U.S., Jan. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07356856) titled 'Efficacy and Safety of Microtransplantation for Advanced and Relapsed Solid Tumors' on Jan. 13.
Brief Summary: In this study, microtransplantation (MST) will be administrated to patients diagnosed with advanced / relapsed solid tumors to assess the therapeutic efficacy and safety of conventional chemotherapy in combination with MST for the treatment of advanced/relapsed solid tumors.
Study Start Date: Jan. 15
Study Type: INTERVENTIONAL
Condition:
Advanced and Relapsed Solid Tumors
Intervention:
BIOLOGICAL: MST
conventional chemotherapy with microtransplantation(MST). Microtransplantation, which is the infusion of granulocyte ...